Authors: KATAYAMA K HAYASHI N KASAHARA A SASAKI Y KASHIWAGI T MASUZAWA M YOSHIHARA H MUKUDA T HORI M

Citation: K. Katayama et al., A PILOT-STUDY OF COMBINATION TREATMENT WITH GAMMA-INTERFERON AND ALPHA-INTERFERON FOR REFRACTORY HEPATITIS-C - RELATIONSHIP BETWEEN VIRAL CLEARANCE AND IMMUNOLOGICAL RESPONSE, Hepatology, 28(4), 1998, pp. 2179-2179

Authors: NAKAZURU S HIJIOKA T HIRAMATSU N SAKAKIBARA M SASAKI K YAKUSHIJIN T MIYAGI T HAYAKAWA Y HOTTA T TABUSE K MUKUDA T

Citation: S. Nakazuru et al., DU-PAN-2-POSITIVE HEPATOCYTES IN FOCAL NODULAR HYPERPLASIA OF THE LIVER, Gastroenterology, 114(4), 1998, pp. 458-458

Authors: OHKAWA K HAYASHI N YUKI N KASAHARA A OSHITA M MOCHIZUKI K KATAYAMA K FUSAMOTO H KATO M MASUZAWA M YOSHIHARA H MUKUDA T KAMADA T

Citation: K. Ohkawa et al., DISEASE STAGE OF CHRONIC HEPATITIS-C ASSESSED BY BOTH PERITONEOSCOPICAND HISTOLOGIC-FINDINGS AND ITS RELATIONSHIP WITH RESPONSE TO INTERFERON THERAPY, Gastrointestinal endoscopy, 45(2), 1997, pp. 168-175

Authors: HAGIWARA H HAYASHI N KASAHARA A OSHITA M KATAYAMA K KATO M MASUZAWA M FUSAMOTO H SAKURAI M KAMADA T FUKUDA M SUGIHARA I NOGUCHI M KASHIO S AKEYAMA T MEREN H KASHIWAGI T KISHIDA Y MUKUDA T HAYAKAWA Y ITOH T ASAI A SHIMIZU Y MIYAMOTO T YOSHIHARA H SUZUKI K TSUMANO M KOJIMA G AKIYAMA M ISHIHARA T KOJIMA J INOUE A FUKUI H

Citation: H. Hagiwara et al., TREATMENT WITH RECOMBINANT INTERFERON-ALPHA-2A FOR PATIENTS WITH CHRONIC HEPATITIS-C - PREDICTIVE FACTORS FOR BIOCHEMICAL AND VIROLOGICAL RESPONSE, Scandinavian journal of gastroenterology, 31(10), 1996, pp. 1021-1026

Authors: TSUJI S KAWANO S HIGASHI T MUKUDA T IMAIZUMI T TATSUMI T MIURA N MIYAJIMA K FUKUDA M NOGUCHI M FUSAMOTO H KAMADA T

Citation: S. Tsuji et al., GASTRIC-ULCER HEALING AND BASIC FIBROBLAST GROWTH-FACTOR - EFFECTS OFLANSOPRAZOLE AND FAMOTIDINE, Journal of clinical gastroenterology, 20, 1995, pp. 1-4

Authors: OKAZAKI T HAYAKAWA Y HIGASHI T MUKUDA T ARAI K YAMADA Y SUZUKI K YOSHIHARA H

Citation: T. Okazaki et al., PROLONGATION OF DAILY ADMINISTRATION OF INTERFERON (IFN)-ALPHA-2A IN PATIENTS WITH CHRONIC HEPATITIS-C (CHC) - EFFICACY AND FEATURES PREDICTIVE OF RESPONSE TO IFN, Gastroenterology, 108(4), 1995, pp. 1137-1137